Atosiban

Active ingredient description

Atosiban is a synthetic peptide which is a competitive antagonist of human oxytocin at receptor level. In human pre-term labour, atosiban at the recommended dosage antagonises uterine contractions and induces uterine quiescence.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Atosiban
G Genito urinary system and sex hormones → G02 Other gynecologicals → G02C Other gynecologicals → G02CX Other gynecologicals
Discover more medicines within G02CX01

Medicines

Atosiban is the active ingredient of these drugs:

Drug
Countries

Brazil

Austria Brazil Cyprus Estonia Finland

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of Product Characteristics (SPC)

Structural formula

Graphic representation of the active ingredient's molecular structure

Molecular mass: 994.19 g/mol

External identifiers

CAS Substance: 90779-69-4
DrugBank Drug: DB09059
KEGG Drug: D03008
RxNorm Ingredient: 59639
SNOMED-CT Concept: 391792002
Atosiban (substance)
UNII Identifier: 081D12SI0Z
ATOSIBAN